Free Trial

DE Burlo Group Inc. Sells 850 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

DE Burlo Group Inc. cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,685 shares of the healthcare conglomerate's stock after selling 850 shares during the quarter. DE Burlo Group Inc.'s holdings in UnitedHealth Group were worth $3,888,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in UNH. Howard Capital Management Group LLC acquired a new position in shares of UnitedHealth Group during the third quarter valued at about $341,000. Principal Financial Group Inc. lifted its holdings in shares of UnitedHealth Group by 11.3% in the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after purchasing an additional 180,479 shares in the last quarter. McIlrath & Eck LLC increased its stake in UnitedHealth Group by 8.2% during the 3rd quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate's stock valued at $371,000 after purchasing an additional 48 shares in the last quarter. SOA Wealth Advisors LLC. increased its position in shares of UnitedHealth Group by 3.7% during the third quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate's stock worth $746,000 after acquiring an additional 46 shares in the last quarter. Finally, Tudor Financial Inc. bought a new position in UnitedHealth Group in the 3rd quarter valued at about $900,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 0.3 %

UNH traded up $1.32 during midday trading on Wednesday, reaching $410.55. 4,090,061 shares of the company's stock traded hands, compared to its average volume of 4,520,543. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 52 week low of $401.28 and a 52 week high of $630.73. The stock has a market capitalization of $373.69 billion, a price-to-earnings ratio of 26.49, a P/E/G ratio of 1.37 and a beta of 0.61. The firm has a fifty day moving average of $499.59 and a two-hundred day moving average of $532.08.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same period in the prior year, the business posted $6.91 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 2.05%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 35.18%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on UNH shares. Piper Sandler decreased their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Morgan Stanley reduced their target price on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Thursday, January 23rd. Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Finally, KeyCorp lowered their price target on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Three research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $596.86.

Get Our Latest Research Report on UnitedHealth Group

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines